Forefront Research

Louisville, Kentucky 40241

0 studies enrolling now · 4 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Psoriasis

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• A Study of LY3471851 in Participants With Psoriasis — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early